Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Osteoporosis
Interventions
DRUG

Ibandronate

DRUG

Alendronate

Trial Locations (38)

2121 BB

GSK Investigational Site, Bennebroek

4834 AD

GSK Investigational Site, Breda

9104 GJ

GSK Investigational Site, Damwoude

3972 WG

GSK Investigational Site, Driebergen-Rijsenburg

5521 CD

GSK Investigational Site, Eersel

5613 BE

GSK Investigational Site, Eindhoven

7544 NZ

GSK Investigational Site, Enschede

4872 LA

GSK Investigational Site, Etten-Leur

6163 GC

GSK Investigational Site, Geleen

6561 CM

GSK Investigational Site, Groesbeek

6417 BR

GSK Investigational Site, Heerlen

7255 AM

GSK Investigational Site, Hengelo

3192 JN

GSK Investigational Site, Hoogvliet

1718 BG

GSK Investigational Site, Hoogwoud

4561 CJ

GSK Investigational Site, Hulst

6373 JS

GSK Investigational Site, Landgraaf

7581 BV

GSK Investigational Site, Losser

1679 GJ

GSK Investigational Site, Midwoud

7442 LS

GSK Investigational Site, Nijverdal

8071 LX

GSK Investigational Site, Nunspeet

8096 AV

GSK Investigational Site, Oldebroek

8734 CG

GSK Investigational Site, Oosterend

4731 MA

GSK Investigational Site, Oudenbosch

4693 BT

GSK Investigational Site, Poortvliet

4841 RR

GSK Investigational Site, Prinsenbeek

8101 ZW

GSK Investigational Site, Raalte

2985 VG

GSK Investigational Site, Ridderkerk

3082 DC

GSK Investigational Site, Rotterdam

3207 NB

GSK Investigational Site, Spijkenisse

2544 KM

GSK Investigational Site, The Hague

2582 LJ

GSK Investigational Site, The Hague

2584 HV

GSK Investigational Site, The Hague

5038 DE

GSK Investigational Site, Tilburg

6367 ED

GSK Investigational Site, Voerendaal

2241 KE

GSK Investigational Site, Wassenaar

9648 BE

GSK Investigational Site, Wildervank

3443 GG

GSK Investigational Site, Woerden

1504 JA

GSK Investigational Site, Zaandam

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY